CIBC Bancorp USA’s Chemed CHE Stock Holding History

CIBC Bancorp USA’s Portfolio CHE Stock Details CHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11M	Buy	23,682 +19,632	+485%	+$8.25M	0.01%	527
2026 Q1	$1.53M	Buy	+4,050	New	+$1.73M	﹤0.01%	959

Other funds holding CHE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

CIBC Bancorp USA's CHE Position: Q2 2026 in Review

CIBC Bancorp USA increased its Chemed (CHE) stake by 485% in Q2 2026, buying an estimated $8.25M and bringing the position to 23,682 shares worth $11M. The position accounts for 0.01% of the portfolio, ranked #527.

CIBC Bancorp USA first reported a position in CHE in Q1 2026 and has held it in 2 quarters since. 532 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

CIBC Bancorp USA held 23,682 shares of Chemed worth $11M as of Q2 2026.
CIBC Bancorp USA bought 19,632 Chemed shares in Q2 2026, an estimated $8.25M.
Chemed made up 0.01% of CIBC Bancorp USA's portfolio in Q2 2026, its #527 holding.
CIBC Bancorp USA first reported a position in Chemed in Q1 2026 and has held it in 2 quarters since.
532 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.